Cargando…

The Ansamycin Antibiotic, Rifamycin SV, Inhibits BCL6 Transcriptional Repression and Forms a Complex with the BCL6-BTB/POZ Domain

BCL6 is a transcriptional repressor that is over-expressed due to chromosomal translocations, or other abnormalities, in ∼40% of diffuse large B-cell lymphoma. BCL6 interacts with co-repressor, SMRT, and this is essential for its role in lymphomas. Peptide or small molecule inhibitors, which prevent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Evans, Sian E., Goult, Benjamin T., Fairall, Louise, Jamieson, Andrew G., Ko Ferrigno, Paul, Ford, Robert, Schwabe, John W. R., Wagner, Simon D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942486/ https://www.ncbi.nlm.nih.gov/pubmed/24595451 http://dx.doi.org/10.1371/journal.pone.0090889

Ejemplares similares

Backbone resonance assignment of the BCL6-BTB/POZ domain
por: Lin, Li-Ying, et al.
Publicado: (2017)

BTB/POZ zinc finger protein ZBTB16 inhibits breast cancer proliferation and metastasis through upregulating ZBTB28 and antagonizing BCL6/ZBTB27
por: He, Jin, et al.
Publicado: (2020)

Functionalization of the BCL6 BTB domain into a noncovalent crystallization chaperone
por: Zacharchenko, Thomas, et al.
Publicado: (2021)

Tumor suppressive BTB/POZ zinc-finger protein ZBTB28 inhibits oncogenic BCL6/ZBTB27 signaling to maintain p53 transcription in multiple carcinogenesis
por: Xiang, Tingxiu, et al.
Publicado: (2019)

Control of inflorescence architecture in tomato by BTB/POZ transcriptional regulators
por: Xu, Cao, et al.
Publicado: (2016)

BTB(BCL6) dimers as building blocks for reversible drug-induced protein oligomerization
por: Nitsch, Lena, et al.
Publicado: (2022)

Novel genes and alleles of the BTB/POZ protein family in Oryza rufipogon
por: Mandal, Swarupa Nanda, et al.
Publicado: (2023)

Mutation in the Plasmodium falciparum BTB/POZ Domain of K13 Protein Confers Artemisinin Resistance
por: Paloque, Lucie, et al.
Publicado: (2022)

Bcl-6 directly represses the gene program of the glycolysis pathway
por: Oestreich, Kenneth J., et al.
Publicado: (2014)

STAT6-mediated BCL6 repression in primary mediastinal B-cell lymphoma (PMBL)
por: Ritz, Olga, et al.
Publicado: (2013)

GmBTB/POZ promotes the ubiquitination and degradation of LHP1 to regulate the response of soybean to Phytophthora sojae
por: Zhang, Chuanzhong, et al.
Publicado: (2021)

High-Grade B-Cell Lymphoma (HGBL) with MYC and BCL2 and/or BCL6 Rearrangements Is Predominantly BCL6-Rearranged and BCL6-Expressing in Taiwan
por: Tsai, Cheng-Chih, et al.
Publicado: (2021)

IL-7 signalling represses Bcl-6 and the T(FH) gene program
por: McDonald, Paul W., et al.
Publicado: (2016)

Rifamycin SV-MMX® as the recommended self-treatment for moderate to severe travellers’ diarrhoea: reply
por: Steffen, Robert, et al.
Publicado: (2019)

Repression of BCL-6 is required for the formation of human memory B cells in vitro
por: Kuo, Tracy C., et al.
Publicado: (2007)

Loss of Transcriptional Repression by BCL6 Confers Insulin Sensitivity in the Setting of Obesity
por: Senagolage, Madhavi D., et al.
Publicado: (2018)

Thermal and Chemical Stability of Two Homologous POZ/BTB Domains of KCTD Proteins Characterized by a Different Oligomeric Organization
por: Pirone, Luciano, et al.
Publicado: (2013)

The POZ/BTB and AT-Hook Containing Zinc Finger 1 (PATZ1) Transcription Regulator: Physiological Functions and Disease Involvement
por: Fedele, Monica, et al.
Publicado: (2017)

Making memories with Bcl-6
por: Read, Kaitlin A., et al.
Publicado: (2021)

Bcl-XL and Bcl-2 repress a common pathway of cell death
Publicado: (1995)

Dynamic repression by BCL6 controls the genome-wide liver response to fasting and steatosis
por: Sommars, Meredith A, et al.
Publicado: (2019)

Core-rod myopathy due to a novel mutation in BTB/POZ domain of KBTBD13 manifesting as late onset LGMD
por: Garibaldi, Matteo, et al.
Publicado: (2018)

Significance of Bcl-2 and Bcl-6 immunostaining in B-Non Hodgkin's lymphoma
por: Mahmoud, Hanan Mohamed, et al.
Publicado: (2011)

Molecularly Stratified Treatment Options in Primary Refractory DLBCL/HGBL with MYC and BCL2 or BCL6 Rearrangements (HGBL, NOS with MYC/BCL6)
por: Witte, Hanno M., et al.
Publicado: (2023)

The chromosomal association/dissociation of the chromatin insulator protein Cp190 of Drosophila melanogaster is mediated by the BTB/POZ domain and two acidic regions
por: Oliver, Daniel, et al.
Publicado: (2010)

BTB/POZ domain‐containing protein 7/hypoxia‐inducible factor 1 alpha signalling axis modulates hepatocellular carcinoma metastasis
por: Hu, Kuan, et al.
Publicado: (2021)

The BTB/POZ zinc finger protein Broad-Z3 promotes dendritic outgrowth during metamorphic remodeling of the peripheral stretch receptor dbd
por: Scott, Janet A, et al.
Publicado: (2011)

POZ/BTB and AT-Hook-Containing Zinc Finger Protein 1 (PATZ1) Suppresses Progression of Ovarian Cancer and Serves as an Independent Prognosis Factor
por: Zhao, Cuihong, et al.
Publicado: (2018)

Development of a new travellers’ diarrhoea clinical severity classification and its utility in confirming rifamycin-SV efficacy
por: DuPont, Herbert L, et al.
Publicado: (2023)

Hit-and-run lymphomagenesis by the Bcl6 oncogene
por: Green, Michael R, et al.
Publicado: (2014)

Rifamycin SV-MMX(®) for treatment of travellers’ diarrhea: equally effective as ciprofloxacin and not associated with the acquisition of multi-drug resistant bacteria
por: Steffen, Robert, et al.
Publicado: (2018)

Selective targeting of BCL6 induces oncogene addiction switching to BCL2 in B-cell lymphoma
por: Dupont, Thibault, et al.
Publicado: (2015)

C-MYC, BCL2 and BCL6 Translocation in B-cell Non-Hodgkin Lymphoma Cases
por: Salam, Dayang Sharyati Datu Abdul, et al.
Publicado: (2020)

TdT Positive Lymphoma with MYC, BCL2 and BCL6 Rearrangements: A Review of Diagnosis and Treatment
por: Singh, Aditi, et al.
Publicado: (2022)

BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia
por: Hurtz, Christian, et al.
Publicado: (2011)

BCL6 positively regulates AID and germinal center gene expression via repression of miR-155
por: Basso, Katia, et al.
Publicado: (2012)

Cortical Neurogenesis Requires Bcl6-Mediated Transcriptional Repression of Multiple Self-Renewal-Promoting Extrinsic Pathways
por: Bonnefont, Jerome, et al.
Publicado: (2019)

NAC1 attenuates BCL6 negative autoregulation and functions as a BCL6 coactivator of FOXQ1 transcription in cancer cells
por: Gao, Min, et al.
Publicado: (2020)

Chronic simian immunodeficiency virus infection is associated with contrasting phenotypes of dysfunctional Bcl6(+) germinal center B cells or Bcl6(−)Bcl2(+) non‐germinal center B cells
por: Onabajo, Olusegun O., et al.
Publicado: (2018)

The epigenetic regulator CTCF modulates BCL6 in lymphoma
por: Batlle-López, Ana, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_429s3rq5e88pcpkkhn5rie72sq